TRDA

ENTRADA THERAPEUTICS, INC.

About TRDA

Entrada Therapeutics, Inc. (Entrada) is a biopharmaceutical company aiming to transform the lives of patients by establishing a set of medicines, Endosomal Escape Vehicles (EEV) therapeutics, to engage intracellular targets that are considered inaccessible and undruggable. The Company's EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its EEV Platform, Entrada is building a development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular diseases, immunology, oncology and diseases of the central nervous system. The Company's lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD), and a follow-on program targeting myotonic dystrophy type 1 (DM1). DMD is a monogenic X-linked disease caused by mutations in the DMD gene.

Buy US stocks in Australia starting with TRDA. Open an account and start investing today!

Market Capitalisation

$366.51M

Price-earnings ratio

Dividend yield

0.00%

Volume

17.71K

High today

$12.47

Low today

$11.79

Open price

$11.85

52-week high

$24.38

52-week low

$5.12

TRDA FAQs

How much is one share of ENTRADA THERAPEUTICS, INC.?

One share of ENTRADA THERAPEUTICS, INC. is valued at $11.96.

What is the ticker symbol for ENTRADA THERAPEUTICS, INC.?

The ticker symbol for ENTRADA THERAPEUTICS, INC. is TRDA.

How do I buy TRDA shares in Australia?

To buy TRDA stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in TRDA

What is the market capitalisation of ENTRADA THERAPEUTICS, INC. TRDA?

As of 28/01/2023 ENTRADA THERAPEUTICS, INC. has a market cap of $367M.

What is the 52-week high for ENTRADA THERAPEUTICS, INC. stock?

The ENTRADA THERAPEUTICS, INC. 52-week high stock price is $24.38.

What is the 52-week low for ENTRADA THERAPEUTICS, INC. stock?

The ENTRADA THERAPEUTICS, INC. 52-week low stock price is $5.12.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.